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Background: Lymphocytopenia has frequently been described in patients with malaria, but studies on its
association with disease severity have yielded conflicting results. The neutrophil/lymphocyte count ratio (NLCR) has
been introduced as a parameter for systemic inflammation in critically ill patients and was found, together with
lymphocytopenia, to be a better predictor of bacteraemia than routine parameters like C-reactive protein and total
leukocyte count. In the present study, the predictive value of the NLCR and lymphocytopenia for severe disease
was evaluated in patients with imported malaria.
Methods: All patients diagnosed with malaria at the Harbour Hospital between January 1st 1999 and January 1st
2012 with differential white cell counts determined within the first 24 hours after admission were included in this
retrospective study. Severe malaria was defined according to the WHO criteria. The performance of the NLCR and
lymphocytopenia as a marker of severe malarial disease was compared back-to-back with that of C-reactive protein
as a reference biomarker.
Results: A total of 440 patients (severe falciparum malaria n = 61, non-severe falciparum malaria n = 259, non-
falciparum malaria n=120) were included in the study. Lymphocytopenia was present in 52% of all patients and the
median NLCR of all patients was 3.2. Total lymphocyte counts and NLCR did not differ significantly between groups.
A significant correlation of total leukocyte count and NLCR, but not lymphocyte count, with parasitaemia was
found. ROC analysis revealed a good negative predictive value but a poor positive predictive value of both
lymphocytopenia and NLCR and performance was inferior to that of C-reactive protein. After complete parasite
clearance a significant rise in total leukocyte count and lymphocyte count and a significant decrease in NLCR was
observed.
Conclusion: The NLCR was found to correlate with parasitaemia, but both lymphocytopenia and the NLCR were
inferior to C-reactive protein as markers for severe disease in patients with imported malaria. The NLCR and
lymphocytopenia are not useful as predictive markers for severe disease in imported malaria in the acute care
setting.
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Changes in blood cell counts are a well-known feature
of malaria. Alterations in leukocyte counts are often less
pronounced than in the other blood cell lineages, but in
general total leukocyte counts have been found to be
low to normal in malaria [1,2]. Lymphocytopenia has
frequently been described in malaria patients in endemic
areas [3-6], and was found to be present in 63% of pa-
tients with imported Plasmodium falciparum infection
[7]. Studies on the correlation between lymphocyte
count and malaria severity yielded conflicting results, as
both lymphocytopenia [1,3,4] and lymphocytosis [8] have
been reported to be associated with adverse outcome.
Lymphocytopenia accompanied by a rise in neutrophil
count is commonly seen in various infectious and non-
infectious causes of systemic inflammation and stress
[9-13]. Zahorec et al. introduced the ratio of neutrophil to
lymphocyte count as a parameter of systemic inflammation
and stress in critically ill surgical and medical patients [14].
The predictive value of both lymphocytopenia and the
neutrophil-lymphocyte count ratio (NLCR) for bacteraemia
was confirmed in a study in an emergency care setting, in
which these parameters were found to be better predictors
of bacteraemia than routine parameters like C-reactive
protein (CRP) level, total leukocyte count or neutrophil
count. Recently, another study evaluated this parameter in
patients with a community-acquired pneumonia (CAP)
[15] and it was found to predict severity and outcome of
CAP with a higher prognostic accuracy as compared with
traditional infection markers.
Although the NLCR is currently not routinely used as
a clinical parameter, the above mentioned studies have
demonstrated its value as an infection marker in critic-
ally ill patients. Unequivocal data concerning the pre-
dictive value of lymphocytopenia and the NLCR in
malaria are not yet available.
In non-endemic countries, where malaria is only seen
as an imported disease, non-specialized hospitals often
rely on rapid diagnostic tests for the diagnosis of malaria
and generally lack experience in the examination of thick
and thin blood smears to asses the parasite load. There
is, therefore, still a need for simple and readily available
parameters for the early identification of patients at risk
of severe or complicated disease. The present study eval-
uated lymphocytopenia and the NLCR as predictive




The Harbour Hospital is a 161-bed general hospital lo-
cated in Rotterdam, The Netherlands. It also comprises
the Institute of Tropical Diseases, which serves as a na-
tional referral centre. All patients diagnosed with malariaat our centre are included in the Rotterdam Malaria Co-
hort study. Demographic, clinical and laboratory data of
all these patients are collected using a standardized form
and stored in an electronic database. For the present ob-
servational cohort study, patients diagnosed with malaria
between January 1st 1999 and January 1st 2012 and with
differential white cell counts determined within the first
24 hours after admission were included.
Laboratory investigations
Total and differential leukocyte counts were measured
using an automatic cell counters. During the study
period three distinct cell counters were subsequently
used after careful calibration (Sysmex NE 8000 [in the
period January 1st 1999 -July 31st 2002], Beckman
Coulter HMX [July 31st 2002- July 31st 2010] and
Sysmex XE 2100 [July 31st 2010 - January 1st 2012], re-
spectively). Absolute numbers of lymphocytes and neu-
trophil subsets were obtained by multiplication of the
absolute leukocyte counts with their respective differen-
tial leukocyte counts. Manual confirmation of automatic
cell count results was performed when immature or ab-
errant leukocytes, erythrocytes or platelet clumps were
detected and when cell count results differed substan-
tially from normal values. Other available laboratory ex-
aminations included red blood cell counts, haematocrit,
platelet counts, C-reactive protein levels, serum electro-
lytes, total bilirubin, serum creatinine and urea, sodium,
potassium, liver enzymes, blood glucose and venous
plasma lactate.
Detection of Plasmodium parasites
The standard procedure to diagnose malaria comprised
a Quantitative Buffy Coat (QBC) analysis, a rapid diag-
nostic test (RDT) for malaria antigens (Binax NOWW
Malaria Test Binax, Inc. Maine, USA), and thick and
thin blood smears using freshly collected blood speci-
mens from finger pricks. The RDT and the QBC analysis
were performed according to the manufacturer’s instruc-
tions. QBC capillaries were examined independently by
two technicians by microscopic analysis of two complete
rows of the region between the bottom of the capillary
and the polynuclear leukocyte layer using an Olympus
BX-60 fluorescence microscope equipped with UV-filter,
50x objective and 12.5x oculars (total magnification
625x). These two lanes represent about 100 microscopic
fields (at 625 × magnification) and take an average
examination time of 5 min. Subsequently, the poly-
nuclear and mononuclear cell layer was screened for
schizonts, gametocytes, malaria pigment and elderly tro-
phozoites of Plasmodium vivax and Plasmodium ovale.
Thick blood smears were stained with Field’s stain
(Brunschwig Chemie, Amsterdam, the Netherlands) and
thin smears with Diff Quick stain (Medion Diagnostics,
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been optimized for optimal staining of Plasmodium par-
asites as well as Schüffner’s dots and Maurer’s clefts in
infected erythrocytes. Thick and thin smears were exam-
ined with regular light microscopes at a total magnifica-
tion of 1250x.
The same Plasmodium detection methods were used
throughout the whole study period.
Definitions
Severe malaria
Patients were classified as having severe malaria if they
met one or more of the WHO criteria for severe malaria,
as published [16], either on presentation or later during
hospital admission.
Leukocyte counts and NLCR
Leukocytopenia was defined as a leukocyte count of less
than 4.0 × 109/L and leukocytosis was defined as a
leukocyte count exceeding 10.0 × 109/L. Lymphocytopenia
was defined as a lymphocyte count of less than 1.0 × 109/L
and lymphocytosis as a lymphocyte count more than
4.0 × 109/L. Neutropenia was defined as a neutrophil
count of less than 1.5 × 109/L and neutrophilia as a neu-
trophil count of more than 7.0 × 109/L. The neutrophil-
lymphocyte count ratio was defined as the ratio of the
absolute neutrophil count to the absolute lymphocyte
count.
Estimation of immunity to P. falciparum
The degree of immunity to malaria was estimated as
previously described [17]. Adult immigrants from a
malaria-endemic country living in the Netherlands were
considered partially immune, because they had likely
been exposed to P. falciparum during childhood.
Patients who had been living in a malaria-endemic
area for at least 2 years at the time of diagnosis were
presumed semi-immune. Tourists from non-endemic
regions who travelled to endemic areas were considered
non-immune.
Statistical analysis
Data were not normally distributed (Kolmogorov-Smirnov
test) and are therefore presented as medians and range.
Univariate comparisons were performed using the Chi-
Square test and the Kruskall-Wallis test with Dunn’s post-
hoc tests (three groups), or the Mann–Whitney test and
Fisher’s Exact test (two groups). Correlations with parasit-
aemia were calculated using Spearman’s rank correlation.
For the comparisons of differential leukocyte counts be-
fore and after treatment, Wilcoxon’s matched pairs test
was used.
For clinical reference, the diagnostic performance of
NLCR and lymphocytopenia for severe disease wascompared to that of the classic biomarker serum CRP
using receiver operating characteristic (ROC) analysis.
The optimal cut-off point was identified using Youden’s
index. The areas under the ROC curve (AUROCs) were
compared to that of CRP in a pair-wise comparison by
the method of Hanley and McNeil [18].
Ethical approval
Given its retrospective observational design, ethical ap-
proval of this study was not required, according to the
Dutch Medical Research Involving Human Subjects Act.
Results
Patient characteristics
Between January 1st 1999 and January 1st 2012 a total of
562 cases of imported malaria were seen. Differential
leukocyte counts were available for 440 (78%) of the pa-
tients. Of these cases, 120 cases were caused by non-
falciparum Plasmodium species: 88 by P. vivax, 27 by P.
ovale, four by Plasmodium malariae and one by Plasmo-
dium knowlesi. The majority of infections (320 or 72%)
was caused by P. falciparum, including three patients
who had a mixed infection; two with P. falciparum and
P. ovale, one with P. falciparum and P. vivax. Sixty-one
patients were classified as having severe malaria. All
these patients met the severity criteria upon admission
to the hospital, and no patients were re-classified as
having severe malaria because of progression of disease
during admission. Concomitant infection was present in
29 (7%) of patients and was more common in patients
with severe malaria. None of the patients had positive
blood cultures. The general characteristics of these pa-
tients are shown in Table 1.
Leukocyte counts and NLCR
Leukocytopenia was present in 23% (100/440) of all
patients but in only 11% (7/61) of patients with severe
malaria (Figure 1). Leukocytosis was seen in 4% (19/440)
of all patients and was more common in patients with
severe disease (13% or 8/61) compared to those with
non-severe falciparum malaria (2% or 6/259) and non-
falciparum malaria (4% or 5/120). Likewise, leukocyte
counts were higher in patients with severe malaria com-
pared to those with non-severe P. falciparum malaria
and non-falciparum malaria (Table 1).
Lymphocytopenia was present in 52% (227/440) of all
patients and was more frequently seen in patients with
non-severe falciparum malaria (143/259 or 55%) than in
patients with severe malaria (28/61 or 46%), and non-
falciparum malaria (54/120 or 45%). Absolute lympho-
cyte counts did not differ significantly between the three
groups.
Neutropenia was found in 8% (36/440) of all patients
and neutrophilia in 4% (17/440), but was more common
Table 1 General characteristics
Severe P. falciparum Non-severe P. falciparum Non-falciparum P value
n=61 n=259 n=120
Demographics
Age, years 44 (4–70) 39 (11–78) 36 (15–77) 0.0005*
Male/female, n (%) 39 (64%)/ 22 (36%) 191 (74%) / 68 (26%) 83 (69%)/37 (31%) NS#
Immunity to P. falciparum 0.0029#
Non-immune 42 (69%) 123 (47%) N/A
Partially immune 19 (31%) 118 (46%) N/A
Semi-immune 0 (0%) 3 (1%) N/A
Unknown 0 (0%) 16 (6%) N/A
Continent of acquisition NS#
Africa, n (%) 56 (92%) 240 (93%) 42 (35%)
Asia, n (%) 3 (5%) 11 (4%) 50 (42%)
South and Central America, n (%) 1 (2%) 5 (2%) 26 (22%)
Unknown, n (%) 1 (2%) 3 (1%) 2 (2%)
Duration of signs/symptoms 0.007#
<8 days, n (%) 38 (62%) 177 (68%) 58 (48%)
8-14 days, n (%) 17 (28%) 45 (17%) 24 (20%)
15-28 days, n (%) 2 (3%) 20 (8%) 11 (9%)
>28 days, n (%) 0 (0%) 5 (2%) 8 (7%)
Unknown, n (%) 4 (7%) 12 (5%) 19 (16%)
Use of malaria chemoprophylaxis <0.0001#
No chemoprophylaxis, n (%) 49 (80%) 182 (70%) 51 (43%)
Inadequate use, n (%) 8 (13%) 46 (18%) 15 (13%)
Adequate use, n (%) 2 (3%) 20 (8%) 42 (35%)
Unknown, n (%) 2 (3%) 11 (4%) 12 (10%)
Vital signs on admission
Body temperature, °C 38.4 (35.7-41.2) 38.5 (35.5-41.0) 38.9 (36.0-41.2) NS*
Pulse rate, beats per minute 103 (50–150) 90 (45–140) 90 (58–138) 0.0005*
Systolic blood pressure, mm Hg 117 (80–160) 120 (73–185) 120 (90–196) N.T.
Impaired consciousness (GCS<15), n (%) 8 (13%) 1 (0%) 0 (0%) N.T.
Coma (GCS≤11), n (%) 3 (5%) 0 (0%) 0 (0%) N.T.
Laboratory data on admission
Haemoglobin, mmol/L 7.8 (2.5-10.9) 8.4 (4.0-11.1) 8.2 (4.6-11.2) N.T.
Thrombocytes, × 109/L 39 (3–188) 101 (18–293) 95 (10–292) <0.0001*
C-reactive protein, mg/L 182 (65–476) 85 (5–320) 71 (14–348) <0.0001*
Serum creatinine, μmol/L 114 (39–1081) 93 (47–238) 90 (53–255) N.T.
Serum sodium, mmol/L 131 (115–146) 135 (119–145) 135 (124–148) <0.0001*
Lactate dehydrogenase, U/L 485 (139–2038) 268 (118–947) 246 (127–775) <0.0001*
Total bilirubin, μmol/L 53 (13–416) 22 (4–164) 22 (3–99) N.T.
Plasma lactate, mmol/L 2.3 (0.6-6.2) 1.4 (0.5-4.6) 1.3 (0.6-4.0) <0.0001*
Leukocyte counts
Total leukocyte count, × 109/L 6.9 (2.5-18.5) 4.9 (1.3-13.4) 5.3 (1.9-15.3) <0.0001*
Neutrophil count, × 109/L 3.6 (0.6-10.4) 3.1 (0.4-11.0) 3.2 (1.0-11.6) 0.0064*
Neutrophil count% 60 (19–85) 64 (13–91) 64 (20–88) NS*
Lymphocyte count, × 109/L 1.0 (0.2-4.2) 0.9 (0.1-5.0) 1.1 (0.3-6.1) NS*
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Table 1 General characteristics (Continued)
Lymphocyte count % 15 (4–45) 19 (2–74) 21 (5–74) 0.0036*
NLCR 3.5 (0.7-17.0) 3.3 (0.2-46) 2.8 (0.3-17.6) NS*
Parasite count
P.falciparum load (asexual parasites/μL) 230,000 (520–1,380,600) 4,288 (2–208,000) N/A N.T.
Presence of P. falciparum schizonts%) 33 (54%) 11 (4%) N/A <0.0001^
Concomitant infection
All concomitant infections 8 (13%) 11 (4%) 10 (8%) <0.0001#
Concomitant bacterial infection 5 (8%) 3 (1%) 2 (2%) 0.004#
* Comparison of 3 groups using the Kruskal Wallis test, # Comparison of 3 groups using the Chi-Square Test, ^ Comparison of 2 groups using Fisher’s Exact test.
Parameters that are included in the modified WHO severity criteria for severe falciparum malaria were not tested (N.T.).
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to those with non-severe falciparum malaria and non-
falciparum malaria (3% or 7/259 and 5% or 6/120, re-
spectively). Neutrophil counts were higher in patients
with severe malaria compared to those with non-
severe P. falciparum malaria and non-falciparum mal-
aria (Table 1).
The median NLCR of all patients was 3.2. Although
there was a trend towards higher values in patients with
severe malaria (3.5) compared to those with non-severeFigure 1 Distribution of leukocyte counts and the NLCR in patients withP. falciparum (3.3) and non-falciparum (2.8) malaria,
these differences were not significant.Correlation with parasitaemia
Significant correlations were found between parasitaemia
and total leukocyte count (rs 0.304, p<0.0001) and para-
sitaemia and NLCR (rs 0.165, p=0.03).
Correlations between parasitaemia and absolute lympho-
cyte or neutrophil counts were not significant.malaria grouped by severity and causative Plasmodium species.
Table 2 Descriptive statistics of diagnostic performance for severe malaria
Parameter Cut-off value Sensitivity Specificity PPV NPV Youden’s AUROC
Total leukocyte count ≥ 6.5 × 109/L 0.59 (0.46-0.71) 0.75 (0.71-0.80) 0.28 (0.21-0.37) 0.92 (0.88-0.95) 0.34 0.70 (0.63-0.78)
Neutrophil count ≥ 3.4 × 109/L 0.64 (0.51-0.76) 0.56 (0.51-0.61) 0.19 (0.14-0.25) 0.91 (0.86-0.94) 0.2 0.61 (0.53-0.69)
Lymphocyte count < 0.7 × 109/L 0.33 (0.22-0.46) 0.72 (0.67-0.76) 0.16 (0.10-0.24) 0.87 (0.83-0.90) 0.05 0.51 (0.43-0.59)
NLCR ≥ 2.8 0.77 (0.64-0.86) 0.44 (0.39-0.49) 0.18 (0.14-0.24) 0.92 (0.87-0.96) 0.21 0.57 (0.50-0.64)
CRP >141 mg/L 0.80 (0.67-0.89) 0.76 (0.71-0.80) 0.33 (0.25-0.42) 0.96 (0.93-0.98) 0.56 0.84 (0.79-0.89)
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Analysis of the diagnostic performance of lymphocytopenia
and the NLCR for the detection of severe malaria revealed
good negative predictive value (0.87 and 0.92 respectively)
but poor positive predictive value (Table 2). The AUROCs
of total leukocyte count, neutrophil count, lymphocyte
count and NLCR were all significantly inferior to that of
CRP (Table 2).
Leukocyte count changes during malaria treatment
Follow-up differential leukocyte counts were available
for 40 (66%) patients with severe malaria and 114 pa-
tients with non-severe P. falciparum infection. By the
time of complete parasite clearance (confirmed by a
negative QBC and thick blood smear) a significant rise
in total leukocyte count and lymphocyte count and a
significant decrease in NLCR was observed. A significant
decrease in neutrophil counts after treatment was only
seen in non-severe malaria patients, but not in patients
with severe malaria (Table 3).
Discussion
In contrast to studies in bacterial sepsis, where lympho-
cytopenia and NLCR were found to outperform CRP
in predicting the presence of bacteraemia, lymphocyte
counts and NLCR did not allow for an accurate discrim-
ination between malaria patients with severe disease and
those without. Even though lymphocytopenia and NLCRTable 3 Leukocyte count changes during malaria treatment
On admission U
Severe P. falciparum
CRP, mg/L 184 (108–373)
Total leukocyte count, x 109/L 6.8 (2.5-18.5)
Neutrophil count, x 109/L 3.5 (1.2-10.4)
Lymphocyte count, x 109/L 0.9 (0.2-4.2)
NLCR 4.0 (0.9-17.0)
Non-severe P. falciparum
CRP, mg/L 96 (5–284)
Total leukocyte count, x 109/L 4.8 (1.3-13.4)
Neutrophil count, x 109/L 3.0 (0.6-8.8)
Lymphocyte count, x 109/L 0.9 (0.2-3.1)
NLCR 3.3 (0.5-19.0)had good negative predictive values, CRP was found to
be a superior marker in back-to-back analyses.
This lack of diagnostic power might partly be due to the
fact that neutrophilia, while often marked in patients with
bacterial sepsis, is not commonly seen in malaria. Some
studies even report neutropenia [1]. In the present study,
neutrophil counts were in the lower range of normal. This
is reflected in NLCR values that are much lower than
those found in patients with bacteraemia [19] and might
be an explanation for the dissimilar performance of the
NLCR in bacterial sepsis and malaria. Bacterial co-
infection was present in 8% of patients with severe mal-
aria, which is consistent with the findings of a large cohort
study on patients with severe malaria admitted to the ICU
[20]. However, none of the patients in the present study
had a positive blood culture. A major confounding effect
of concomitant bacterial infections is, therefore, unlikely.
Moreover, regarding the design of the study on NLCR in
bacterial sepsis by de Jager et al. [19], an important differ-
ence with the present study has to be taken into account.
In the former study, lymphocytopenia and the NLCR were
evaluated as predictors of the presence of bacteraemia in
patients with suspected community-acquired bacteraemia,
while in the present study these biomarkers were evalu-
ated in a patient group with confirmed malaria. Consider-
ing this, the correlation of NLCR with peripheral parasite
count and the fact that lymphocyte count increases and
NLCR decreases after complete parasite clearance arepon clearance of parasitaemia n P value
49 (1–206) 29 <0.0001
7.8 (3.1-16.4) 40 0.0045
4.0 (1.4-10.7) 40 NS
2.1 (0.2-5.8) 40 <0.0001
2.1 (0.5-20.3) 40 0.0011
14 (1–250) 116 <0.0001
5.6 (2.2-16.9) 161 <0.0001
2.5 (0.3-11.9) 114 0.0075
2.0 (0.3-4.5) 114 <0.0001
1.3 (0.3-11.0) 114 <0.0001
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power to accurately identify patients with severe mal-
aria, a high parasite load does seem to result in relative
lymphocytopenia.
Surprisingly for such a common phenomenon [3-7,21]
the mechanism behind malaria-associated lymphopenia
has still not been satisfactorily elucidated and remains
the subject of debate [22]. The rapid re-emergence of
lymphocytes in the peripheral circulation following initi-
ation of treatment has led some authors to suggest tran-
sient sequestration during malaria to be responsible
[4,5]. The relatively large drop in peripheral lymphocyte
numbers would suggest this to be a non-specific effect, e.g.
pooling in the enlarged spleens of patients [5] rather than
a response by malaria-specific lymphocytes only. Others
have pointed to the increased propensity of lymphocytes
from malaria patients to undergo spontaneous apoptosis
in vitro [23,24], possibly induced by soluble Fas ligand
(sFasL)-Fas interaction [25]. Interestingly, increased apop-
tosis is also seen in healthy donors from endemic areas, be
it to a lesser extent [23,24,26], suggesting chronic stimula-
tion of lymphocytes by environmental micro-organisms
may be contributing through activation-induced cell
death. Presumably both mechanisms are at work in tan-
dem, with activated lymphocytes sequestering during mal-
aria and rates of apoptosis, whether spontaneous or
activation-induced, rising due to infection and peaking fol-
lowing treatment in order to restore homeostasis [27].
In conclusion, the NLCR was found to correlate with
parasitaemia, but both lymphocytopenia and the NLCR
were inferior to CRP as markers of severe disease in pa-
tients with imported malaria in direct back-to-back com-
parisons. Although these parameters may have proven
their usefulness in predicting bacteraemia, they are ap-
parently not useful as predictive markers of severe dis-
ease in imported malaria in the acute care setting.
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